Amarin reported $-12967000 in Pre-Tax Profit for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Pre Tax Profit Change
Acceleron Pharma XLRN:US $ -70.45M 6.94M
Adamas Pharmaceuticals ADMS:US -19518000 7.17M
Aerie Pharmaceuticals AERI:US $ -33.31M 2.2M
Alnylam Pharmaceuticals ALNY:US $ -212.93M 24.6M
Amarin AMRN:US $ -12.97M 21.83M
Arena Pharmaceuticals ARNA:US $ -126.31M 19.78M
AstraZeneca AZN:LN 1954M 415M
Epizyme EPZM:US $ -65.83M 1.47M
Esperion Therapeutics ESPR:US $ -69386000 25.72M
Halozyme Therapeutics HALO:US $ 74.11M 17.41M
Intercept Pharmaceuticals ICPT:US $ -3.63M 7.46M
IONIS PHARMACEUT IONS:US $ -84M 3M
Nektar Therapeutics NKTR:US $ -129.59M 4.43M
Neurocrine Biosciences NBIX:US $ 30.5M 27M
Novartis NOVN:VX SF 4544M 120M
Teva Pharmaceutical Industries TEVA:US $ 807M 13M